title: Classification of current anticancer immunotherapies.
abstract: During the past decades, anticancer immunotherapy has evolved from a promising therapeutic option to a robust clinical reality. Many immunotherapeutic regimens are now approved by the US Food and Drug Administration and the European Medicines Agency for use in cancer patients, and many others are being investigated as standalone therapeutic interventions or combined with conventional treatments in clinical studies. Immunotherapies may be subdivided into "passive" and "active" based on their ability to engage the host immune system against cancer. Since the anticancer activity of most passive immunotherapeutics (including tumor-targeting monoclonal antibodies) also relies on the host immune system, this classification does not properly reflect the complexity of the drug-host-tumor interaction. Alternatively, anticancer immunotherapeutics can be classified according to their antigen specificity. While some immunotherapies specifically target one (or a few) defined tumor-associated antigen(s), others operate in a relatively non-specific manner and boost natural or therapy-elicited anticancer immune responses of unknown and often broad specificity. Here, we propose a critical, integrated classification of anticancer immunotherapies and discuss the clinical relevance of these approaches.
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Galluzzi
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Erika
authors.initials: E
authors.lastname: Vacchelli
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: José-Manuel
authors.initials: JM
authors.lastname: Bravo-San Pedro
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Aitziber
authors.initials: A
authors.lastname: Buqué
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Laura
authors.initials: L
authors.lastname: Senovilla
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France.
authors.forename: Elisa Elena
authors.initials: EE
authors.lastname: Baracco
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France.
authors.forename: Norma
authors.initials: N
authors.lastname: Bloy
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Faculté de Medicine, Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France. Sotio a.c., Prague, Czech Republic.
authors.forename: Francesca
authors.initials: F
authors.lastname: Castoldi
authors.affiliation: Pole d'innovation thérapeutique en oncologie, Institut de Recherches Internationales Servier, Suresnes, France.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Abastado
authors.affiliation: Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Agostinis
authors.affiliation: The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
authors.forename: Ron N
authors.initials: RN
authors.lastname: Apte
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Gustave Roussy Cancer Campus, Villejuif, France. Group of Immune receptors of the Innate and Adaptive System, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Aranda
authors.affiliation: INSERM, U1102, Saint Herblain, France. Institut de Cancérologie de l'Ouest, Saint Herblain, France.
authors.forename: Maha
authors.initials: M
authors.lastname: Ayyoub
authors.affiliation: Translational Immunology Division, German Cancer Research Center, Heidelberg, Germany.
authors.forename: Philipp
authors.initials: P
authors.lastname: Beckhove
authors.affiliation: Equipe 11, Centre Léon Bérard (CLR), Lyon, France. Centre de Recherche en Cancérologie de Lyon (CRCL), Lyon, France.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Blay
authors.affiliation: Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: Bracci
authors.affiliation: INSERM, U1160, Paris, France. Groupe Hospitalier Saint Louis-Lariboisière - F. Vidal, Paris, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Caignard
authors.affiliation: Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Castelli
authors.affiliation: Molecular Biotechnology Center, Dept. of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Cavallo
authors.affiliation: Cancer Immunology, Inflammation and Tolerance Program, Georgia Regents University Cancer Center, Augusta, GA, USA.
authors.forename: Estaban
authors.initials: E
authors.lastname: Celis
authors.affiliation: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Cerundolo
authors.affiliation: Institute of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK. Velindre Cancer Centre, Cardiff, UK.
authors.forename: Aled
authors.initials: A
authors.lastname: Clayton
authors.affiliation: Unit of Immunotherapy of Human Tumors, Dept. of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
authors.forename: Mario P
authors.initials: MP
authors.lastname: Colombo
authors.affiliation: Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
authors.forename: Lisa
authors.initials: L
authors.lastname: Coussens
authors.affiliation: Sect. of Hematology and Immunobiology, Yale Cancer Center, Yale University, New Haven, CT, USA.
authors.forename: Madhav V
authors.initials: MV
authors.lastname: Dhodapkar
authors.affiliation: Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Alexander M
authors.initials: AM
authors.lastname: Eggermont
authors.affiliation: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
authors.forename: Douglas T
authors.initials: DT
authors.lastname: Fearon
authors.affiliation: INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Equipe 13, Centre de Recherche des Cordeliers, Paris, France.
authors.forename: Wolf H
authors.initials: WH
authors.lastname: Fridman
authors.affiliation: Sotio a.c., Prague, Czech Republic. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
authors.forename: Jitka
authors.initials: J
authors.lastname: Fučíková
authors.affiliation: Dept. of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Dmitry I
authors.initials: DI
authors.lastname: Gabrilovich
authors.affiliation: INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers, Paris, France.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Galon
authors.affiliation: Cell Death Research and Therapy (CDRT) Laboratory, Dept. of Cellular and Molecular Medicine, University of Leuven, Leuven, Belgium.
authors.forename: Abhishek
authors.initials: A
authors.lastname: Garg
authors.affiliation: INSERM, UMR866, Dijon, France. Centre Georges François Leclerc, Dijon, France. Université de Bourgogne, Dijon, France.
authors.forename: François
authors.initials: F
authors.lastname: Ghiringhelli
authors.affiliation: Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Giaccone
authors.affiliation: Dept. of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL, USA.
authors.forename: Eli
authors.initials: E
authors.lastname: Gilboa
authors.affiliation: Sect. of Hematology/Oncology, Immunology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
authors.forename: Sacha
authors.initials: S
authors.lastname: Gnjatic
authors.affiliation: Glaxo Smith Kline, Cancer Immunotherapy Consortium, Collegeville, PA, USA.
authors.forename: Axel
authors.initials: A
authors.lastname: Hoos
authors.affiliation: Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. INSERM, U1016, Paris, France. CNRS, UMR8104, Paris, France. Hôpital Cochin, AP-HP, Paris, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Hosmalin
authors.affiliation: National Center for Tumor Diseases, University Medical Center Heidelberg, Heidelberg, Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Jäger
authors.affiliation: Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA. Dept. of Immunology and Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh, PA, USA.
authors.forename: Pawel
authors.initials: P
authors.lastname: Kalinski
authors.affiliation: Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
authors.forename: Klas
authors.initials: K
authors.lastname: Kärre
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Oliver
authors.initials: O
authors.lastname: Kepp
authors.affiliation: Dept. of Oncology, Karolinska Institute Hospital, Stockholm, Sweden.
authors.forename: Rolf
authors.initials: R
authors.lastname: Kiessling
authors.affiliation: University of Pittsburgh Cancer Institute Laboratory, Pittsburgh, PA, USA.
authors.forename: John M
authors.initials: JM
authors.lastname: Kirkwood
authors.affiliation: Dept. of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
authors.forename: Eva
authors.initials: E
authors.lastname: Klein
authors.affiliation: National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.
authors.forename: Alexander
authors.initials: A
authors.lastname: Knuth
authors.affiliation: Academic Unit of Inflammation and Tumour Targeting, Dept. of Oncology, University of Sheffield Medical School, Sheffield, UK.
authors.forename: Claire E
authors.initials: CE
authors.lastname: Lewis
authors.affiliation: INSERM, UMR1043, Toulouse, France. CNRS, UMR5282, Toulouse, France. Laboratoire d'Immunologie, CHU Toulouse, Université Toulouse II, Toulouse, France.
authors.forename: Roland
authors.initials: R
authors.lastname: Liblau
authors.affiliation: Dept. of Surgery, University of Pittsburgh, Pittsburgh, PA, USA. University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Lotze
authors.affiliation: Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Lugli
authors.affiliation: Dept. of Biochemistry, University of Lausanne, Epalinges, Switzerland.
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Mach
authors.affiliation: Dept. of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Mattei
authors.affiliation: Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Institute, Rozzano, Italy. Dept. of Medical Biotechnologies and Translational Medicine, University of Milan, Rozzano, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: Mavilio
authors.affiliation: Dept. of Immunology, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain. Dept. of Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
authors.forename: Ignacio
authors.initials: I
authors.lastname: Melero
authors.affiliation: ISA Therapeutics, Leiden, The Netherlands. Dept. of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Cornelis J
authors.initials: CJ
authors.lastname: Melief
authors.affiliation: Research Dept. of Surgical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Mittendorf
authors.affiliation: Istituto Giannina Gaslini, Genova, Italy.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Moretta
authors.affiliation: Center for Immunotherapy, Roswell Park Cancer Institute, Buffalo, NY, USA.
authors.forename: Adekunke
authors.initials: A
authors.lastname: Odunsi
authors.affiliation: Dept. of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
authors.forename: Hideho
authors.initials: H
authors.lastname: Okada
authors.affiliation: The Jackson Laboratory for Genomics Medicine, Farmington, CT, USA.
authors.forename: Anna Karolina
authors.initials: AK
authors.lastname: Palucka
authors.affiliation: Div. of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
authors.forename: Marcus E
authors.initials: ME
authors.lastname: Peter
authors.affiliation: The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD, USA.
authors.forename: Kenneth J
authors.initials: KJ
authors.lastname: Pienta
authors.affiliation: The Shraga Segal Dept. of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
authors.forename: Angel
authors.initials: A
authors.lastname: Porgador
authors.affiliation: Lankenau Institute for Medical Research, Wynnewood, PA, USA. Dept. of Pathology, Anatomy and Cell Biology, Sidney Kimmel Medical College, Philadelphia, PA, USA. Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: George C
authors.initials: GC
authors.lastname: Prendergast
authors.affiliation: Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Buenos Aires, Argentina.
authors.forename: Gabriel A
authors.initials: GA
authors.lastname: Rabinovich
authors.affiliation: National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
authors.forename: Nicholas P
authors.initials: NP
authors.lastname: Restifo
authors.affiliation: Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA.
authors.forename: Naiyer
authors.initials: N
authors.lastname: Rizvi
authors.affiliation: INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie/Paris VI, Paris, France. Equipe 13, Centre de Recherche des Cordeliers, Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Sautès-Fridman
authors.affiliation: Dept. of Pathology, The Cancer Research Center, The University of Chicago, Chicago, IL, USA.
authors.forename: Hans
authors.initials: H
authors.lastname: Schreiber
authors.affiliation: Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.
authors.forename: Barbara
authors.initials: B
authors.lastname: Seliger
authors.affiliation: Dept. of Immuno-GeneTherapy, Mie University Graduate School of Medicine, Tsu, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shiku
authors.affiliation: Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal.
authors.forename: Bruno
authors.initials: B
authors.lastname: Silva-Santos
authors.affiliation: Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. School of Medicine, University of Queensland, Herston, Queensland, Australia.
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Smyth
authors.affiliation: Dept. of Oncology, University of Lausanne, Lausanne, Switzerland. Ludwig Cancer Research Center, Lausanne, Switzerland.
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Speiser
authors.affiliation: Sotio a.c., Prague, Czech Republic. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic.
authors.forename: Radek
authors.initials: R
authors.lastname: Spisek
authors.affiliation: Dept. of Immunology, University of Connecticut School of Medicine, Farmington, CT, USA. Carole and Ray Neag Comprehensive Cancer Center, Farmington, CT, USA.
authors.forename: Pramod K
authors.initials: PK
authors.lastname: Srivastava
authors.affiliation: Laboratory of Transplantation Immunology, Dept. of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: James E
authors.initials: JE
authors.lastname: Talmadge
authors.affiliation: Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. INSERM, U970, Paris, France. Paris-Cardiovascular Research Center (PARCC), Paris, France. Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Tartour
authors.affiliation: Dept. of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
authors.forename: Sjoerd H
authors.initials: SH
authors.lastname: Van Der Burg
authors.affiliation: Ludwig Institute for Cancer Research, Brussels, Belgium. de Duve Institute, Brussels, Belgium. Université Catholique de Louvain, Brussels, Belgium.
authors.forename: Benoît J
authors.initials: BJ
authors.lastname: Van Den Eynde
authors.affiliation: Dept. of Molecular Medicine and Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Richard
authors.initials: R
authors.lastname: Vile
authors.affiliation: Institute of Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany.
authors.forename: Hermann
authors.initials: H
authors.lastname: Wagner
authors.affiliation: Donald A. Adam Comprehensive Melanoma Research Center, Moffitt Cancer Center, Tampa, FL, USA.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Weber
authors.affiliation: University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA. University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
authors.forename: Theresa L
authors.initials: TL
authors.lastname: Whiteside
authors.affiliation: Dept. of Medicine and Ludwig Center, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, USA. Weill Cornell Medical College, New York, NY, USA.
authors.forename: Jedd D
authors.initials: JD
authors.lastname: Wolchok
authors.affiliation: Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1015, Villejuif, France. Centre d'Investigation Clinique Biothérapie 507 (CICBT507), Gustave Roussy Cancer Campus, Villejuif, France.
authors.forename: Laurence
authors.initials: L
authors.lastname: Zitvogel
authors.affiliation: University of Michigan, School of Medicine, Ann Arbor, MI, USA.
authors.forename: Weiping
authors.initials: W
authors.lastname: Zou
authors.affiliation: Equipe 11 labellisée pas la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. INSERM, U1138, Paris, France. Université Paris Descartes/Paris V, Sorbonne Paris Cité, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou (HEGP), AP-HP, Paris, France.
authors.forename: Guido
authors.initials: G
authors.lastname: Kroemer
mesh_terms: D000818:Animals; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*